Holdings: An Analysis of Pharmaceutical Lending by the World Bank

Cover Image

QR Code

An Analysis of Pharmaceutical Lending by the World Bank

The World Bank (WB) began to lend for health, nutrition, and population (HNP) in the late 1970s. Today, the Bank has become the single largest external source of HNP financing in low- and middle-income countries. The Bank's activities in the H...

Full description

Bibliographic Details
Main Authors:	Rodríguez-Monguió, Rosa, Rovira, Juan
Language:	English en_US
Published:	World Bank, Washington, DC 2013
Subjects:	ANTIBIOTICS APPRAISAL REPORTS BORROWER COMPETITIVE BIDDING CONCESSIONAL LOANS CONTRACEPTIVES COST ACCOUNTING DEVELOPMENT GOALS DRUGS ECONOMICS EXPENDITURES FISCAL YEAR FOREIGN EXCHANGE HEALTH CARE HEALTH SECTOR HEALTH SERVICES HOSPITALS HUMAN CAPITAL INCOME LEGISLATION LENDING DOCUMENTS LENDING INSTRUMENTS LENDING OPERATIONS LOAN LOAN AGREEMENTS MEDICAL SUPPLIES MEDICINE NUTRITION PHARMACEUTICAL PRODUCTS PHARMACEUTICAL SECTOR PHARMACEUTICAL SUPPLIERS PHARMACEUTICALS PRIVATE SECTOR PROCUREMENT PROJECT IMPLEMENTATION PUBLIC HEALTH PUBLIC POLICIES PURCHASING RATIONAL USE OF DRUGS SANITATION SUPPLIERS TECHNICAL ASSISTANCE TRANSPARENCY TRUST FUNDS VACCINES VENEZUELA WATER SUPPLY LENDING
Online Access:	http://documents.worldbank.org/curated/en/2004/09/5621115/analysis-pharmaceutical-lending-world-bank http://hdl.handle.net/10986/13730

Internet

http://documents.worldbank.org/curated/en/2004/09/5621115/analysis-pharmaceutical-lending-world-bank
http://hdl.handle.net/10986/13730